AP2004003021A0 - Vectors, constructs and transgenic plants for HPV-11 and HPV-16 L1 capsid protein. - Google Patents

Vectors, constructs and transgenic plants for HPV-11 and HPV-16 L1 capsid protein.

Info

Publication number
AP2004003021A0
AP2004003021A0 APAP/P/2004/003021A AP2004003021A AP2004003021A0 AP 2004003021 A0 AP2004003021 A0 AP 2004003021A0 AP 2004003021 A AP2004003021 A AP 2004003021A AP 2004003021 A0 AP2004003021 A0 AP 2004003021A0
Authority
AP
ARIPO
Prior art keywords
hpv
cells
constructs
vectors
transgenic plants
Prior art date
Application number
APAP/P/2004/003021A
Other languages
English (en)
Inventor
Arvind Devshi Varsani
Edward Peter Rybicki
Anna-Lise Williamson
Original Assignee
Univ Cape Town
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Cape Town filed Critical Univ Cape Town
Publication of AP2004003021A0 publication Critical patent/AP2004003021A0/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
    • C12N15/8241—Phenotypically and genetically modified plants via recombinant DNA technology
    • C12N15/8242—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits
    • C12N15/8257—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits for the production of primary gene products, e.g. pharmaceutical products, interferon
    • C12N15/8258—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits for the production of primary gene products, e.g. pharmaceutical products, interferon for the production of oral vaccines (antigens) or immunoglobulins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/515—Animal cells
    • A61K2039/5156—Animal cells expressing foreign proteins
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/20011—Papillomaviridae
    • C12N2710/20022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/20011—Papillomaviridae
    • C12N2710/20023—Virus like particles [VLP]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Plant Pathology (AREA)
  • Microbiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Virology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
APAP/P/2004/003021A 2001-08-31 2002-08-30 Vectors, constructs and transgenic plants for HPV-11 and HPV-16 L1 capsid protein. AP2004003021A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ZA200107226 2001-08-31
PCT/IB2002/003532 WO2003018624A1 (fr) 2001-08-31 2002-08-30 Vecteurs, produits de synthese et plantes transgeniques pour proteine capside du hpv-11 et du hpv-16

Publications (1)

Publication Number Publication Date
AP2004003021A0 true AP2004003021A0 (en) 2004-06-30

Family

ID=25589294

Family Applications (1)

Application Number Title Priority Date Filing Date
APAP/P/2004/003021A AP2004003021A0 (en) 2001-08-31 2002-08-30 Vectors, constructs and transgenic plants for HPV-11 and HPV-16 L1 capsid protein.

Country Status (4)

Country Link
CN (1) CN1290859C (fr)
AP (1) AP2004003021A0 (fr)
WO (1) WO2003018624A1 (fr)
ZA (1) ZA200402504B (fr)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2662118T3 (es) * 2005-04-29 2018-04-05 University Of Cape Town Expresión de proteínas virales en las plantas
WO2006065166A1 (fr) * 2005-07-26 2006-06-22 Obschestvo S Ogranichennoi Otvetstvennostyu 'rusgen' Composition de traitement et de prevention de l'infection de l'humain par le papillomavirus sur la base de la proteine l1 et des peptides de la proteine e7
CN100392084C (zh) * 2006-03-13 2008-06-04 曾毅 含密码子优化型hpv16l1基因的重组腺病毒
CN1869215B (zh) * 2006-05-19 2012-07-04 长春百克生物科技股份公司 一种制备人乳头瘤病毒的病毒样颗粒的方法
CN101153280B (zh) * 2006-09-29 2015-08-19 厦门大学 从原核生物中纯化人乳头瘤病毒晚期蛋白l1的方法
US9428555B2 (en) 2007-04-29 2016-08-30 Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. Truncated L1 protein of Human Papillomavirus type 16
WO2008134935A1 (fr) * 2007-04-29 2008-11-13 Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. Protéines 18 l1 de type papillomavirus humain tronqué
BRPI0810959B1 (pt) 2007-05-29 2021-06-29 Xiamen Innovax Biotech Co., Ltd. Proteína l1 do hpv11, polinucleotídeo, vetor, célula, composição, partícula do tipo vírus (vlp) hpv11, método para produzir uma proteína l1 do hpv, vacina para prevenção de condiloma acuminado ou de infecções por hpv e método para produzir uma vacina para prevenção de condiloma acuminado ou infecções por hpv
CN102321635B (zh) * 2011-09-02 2014-02-26 中国农业科学院生物技术研究所 人类乳头瘤病毒空衣壳粒子的制备方法及其产品
CN114539363B (zh) * 2020-11-26 2023-12-01 中国医学科学院基础医学研究所 一种c端改造的人乳头瘤病毒11型l1蛋白及其用途

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10055545A1 (de) * 2000-11-09 2002-07-25 Deutsches Krebsforsch Für Expression in Eukaryonten optimierte HPV 16-L1 und HPV 16-L2 kodierende DNA Sequenzen

Also Published As

Publication number Publication date
CN1290859C (zh) 2006-12-20
WO2003018624A1 (fr) 2003-03-06
ZA200402504B (en) 2005-06-29
CN1578787A (zh) 2005-02-09

Similar Documents

Publication Publication Date Title
AP2004003021A0 (en) Vectors, constructs and transgenic plants for HPV-11 and HPV-16 L1 capsid protein.
WO2007024756A3 (fr) E. coli a genome reduit
MX2007005132A (es) Medios libres de proteina animal para cultivo de celulas.
PL374782A1 (en) Animal protein free media for cultivation of cells
CA2185712A1 (fr) Transfert d'adn par mediation virale renforcee
NO20054889D0 (no) Optimalisert uttrykking av HPV 31 LI i gjaer
CY1114598T1 (el) Μεθοδος για την ενισχυση ενος ιου φυσαλιδωδους νοσου υπο συνθηκες ελευθερες ορου
WO2006046148A3 (fr) Constructions d'arn
WO2011075686A3 (fr) Méthodes et compositions comprenant des protéines de choc thermique
WO2008034388A8 (fr) Particules virales de protéines de la capside provenant du papillomavirus humain de type 16/58/18/6/11 et leur procédé de préparation et leurs utilisations
IL132580A0 (en) Genetically engineered duckweed
WO2001087350A3 (fr) Traitement de cellules infectees par le papillomavirus humain (hpv)
AU2002337083A1 (en) Vaccinia virus mva-e3l-knockout-mutants and use thereof
WO2002031173A3 (fr) Procedes ameliores de biosynthese de la vitamine e
JP4211603B2 (ja) シゾサッカロマイセス・ポンベ（Ｓｃｈｉｚｏｓａｃｃｈａｒｏｍｙｃｅｓｐｏｍｂｅ）宿主の構築方法および異種タンパク質の製造方法
ATE317016T1 (de) Herstellung rekombinanter künstlicher hefe- chromosome, welche das genom des humanen cytomegalovirus enthalten
EP1712243A4 (fr) Therapie genique pour tumeur utilisant un vecteur viral a arn a chaine negative codant une cytokine immunostimulatrice
ATE494377T1 (de) Vakzine gegen ipnv die aus hefezellen isoliert werden
WO2006066229A3 (fr) Elicitation d'anticorps en peptides du soi par immunisation de cellules dentritiques
GB0307089D0 (en) Live vaccine strain
WO2022115490A3 (fr) Vaccin à adn contre le papillomavirus humain et son procédé d'utilisation
WO2007015691A3 (fr) Procedes et compositions destines a accroitre la longevite et la production de proteines dans une culture cellulaire
CA2411649A1 (fr) Piegeage de genes a activation ires dans des plantes
WO2004067750A3 (fr) Proteines et genes de tc de xenorhabdus destines a la lutte antiparasitaire
WO2004020589A3 (fr) Gene pour facteur de transcription dof capable de modifier la taille et la stature d'une plante